Arkema (OTCMKTS:ARKAY) PT Lowered to €100.00 - MarketBeat

2022-10-10 20:45:56 By : Ms. Angela Zhang

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Arkema (OTCMKTS:ARKAY - Get Rating) had its price target dropped by research analysts at Berenberg Bank from €131.00 ($133.67) to €100.00 ($102.04) in a report issued on Monday, The Fly reports.

ARKAY has been the topic of several other reports. UBS Group cut Arkema from a "neutral" rating to a "sell" rating in a research report on Thursday, July 14th. Credit Suisse Group restated an "outperform" rating on shares of Arkema in a report on Wednesday, August 24th. Stifel Nicolaus decreased their price objective on shares of Arkema from €139.00 ($141.84) to €123.00 ($125.51) and set a "buy" rating for the company in a report on Wednesday, July 6th. The Goldman Sachs Group lowered shares of Arkema from a "buy" rating to a "neutral" rating in a report on Thursday, September 1st. Finally, Morgan Stanley decreased their target price on shares of Arkema from €91.00 ($92.86) to €88.00 ($89.80) and set an "underweight" rating for the company in a research note on Wednesday, October 5th. Three equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $116.33.Arkema Stock Performance

Shares of ARKAY stock opened at $71.82 on Monday. The firm has a market cap of $5.34 billion, a price-to-earnings ratio of 4.47, a P/E/G ratio of 3.56 and a beta of 1.40. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.30 and a current ratio of 1.90. Arkema has a 52 week low of $67.88 and a 52 week high of $152.18. The firm's 50-day simple moving average is $83.83 and its two-hundred day simple moving average is $100.44.

Arkema (OTCMKTS:ARKAY - Get Rating) last issued its quarterly earnings data on Friday, July 29th. The basic materials company reported $6.35 EPS for the quarter, beating the consensus estimate of $5.15 by $1.20. Arkema had a net margin of 9.87% and a return on equity of 19.13%. The company had revenue of $3.39 billion during the quarter, compared to analysts' expectations of $3.45 billion. As a group, equities analysts forecast that Arkema will post 15.77 earnings per share for the current year. Arkema Company Profile (Get Rating)

Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates through Adhesive Solutions, Advanced Materials, Coating Solutions, and Intermediates segments. It provides adhesive solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.Recommended StoriesGet a free copy of the StockNews.com research report on Arkema (ARKAY)Clorox Pandemic Gains Have Been Bleached, Time to Get Back In? Could the Crash of the Pound Cause the Fed to Blink on Rates?2 Regional Banks With Sector-Beating Price PerformanceMarketBeat: Week in Review 10/3-10/7ConAgra Brands Is A Value Pick For Income Investors 

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Arkema, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.

While Arkema currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Kirk McDonald shares three stocks from different industries with different market caps and explains why each is a holding in his portfolio.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.